Marker Therapeutics (MRKR) Non-Current Debt (2022 - 2023)
Marker Therapeutics (MRKR) has disclosed Non-Current Debt for 3 consecutive years, with $97400.0 as the latest value for Q1 2023.
Marker Therapeutics (MRKR) has disclosed Non-Current Debt for 3 consecutive years, with $97400.0 as the latest value for Q1 2023.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month